Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium.

Burnett-Hartman AN, Kamineni A, Corley DA, Singal AG, Halm EA, Rutter CM, Chubak J, Lee JK, Doubeni CA, Inadomi JM, Doria-Rose VP, Zheng Y.

EGEMS (Wash DC). 2019 Aug 2;7(1):37. doi: 10.5334/egems.296.

2.

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk.

Frenette CT, Isaacson AJ, Bargellini I, Saab S, Singal AG.

Mayo Clin Proc Innov Qual Outcomes. 2019 Jul 11;3(3):302-310. doi: 10.1016/j.mayocpiqo.2019.04.005. eCollection 2019 Sep.

3.

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM.

Cancer Res. 2019 Sep 1;79(17):4326-4330. doi: 10.1158/0008-5472.CAN-19-0803.

PMID:
31481419
4.

Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial.

Mokdad AA, Zhu H, Beg MS, Arriaga Y, Dowell JE, Singal AG, Yopp AC.

Target Oncol. 2019 Aug 19. doi: 10.1007/s11523-019-00663-3. [Epub ahead of print]

PMID:
31429027
5.

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Moon AM, Singal AG, Tapper EB.

Clin Gastroenterol Hepatol. 2019 Aug 8. pii: S1542-3565(19)30849-3. doi: 10.1016/j.cgh.2019.07.060. [Epub ahead of print] Review.

PMID:
31401364
6.

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies.

Liang J, Zhu J, Wang M, Singal AG, Odewole M, Kagan S, Renteria V, Liu S, Parikh ND, Lubman DM.

Sci Rep. 2019 Aug 9;9(1):11580. doi: 10.1038/s41598-019-48043-1.

7.

Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma.

Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC.

Gastroenterology. 2019 Jul 30. pii: S0016-5085(19)41137-2. doi: 10.1053/j.gastro.2019.07.040. [Epub ahead of print]

PMID:
31374215
8.

Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma.

Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette C, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG.

Clin Gastroenterol Hepatol. 2019 Jul 26. pii: S1542-3565(19)30786-4. doi: 10.1016/j.cgh.2019.07.042. [Epub ahead of print]

PMID:
31357028
9.

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores.

Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK, Sterling RK, Feld JJ, Kaplan DE, Taddei TH, Berry K.

Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41130-X. doi: 10.1053/j.gastro.2019.07.033. [Epub ahead of print]

PMID:
31356807
10.

Prevalence and clinical significance of discordant LI-RADS® observations on multiphase contrast-enhanced MRI in patients with cirrhosis.

Yokoo T, Singal AG, Diaz de Leon A, Ananthakrishnan L, Fetzer DT, Pedrosa I, Khatri G.

Abdom Radiol (NY). 2019 Jul 24. doi: 10.1007/s00261-019-02133-w. [Epub ahead of print]

PMID:
31342103
11.

Reply.

Singal AG.

Gastroenterology. 2019 Sep;157(3):901-902. doi: 10.1053/j.gastro.2019.07.011. Epub 2019 Jul 12. No abstract available.

PMID:
31306633
12.

Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma.

Hester CA, Karbhari N, Rich NE, Augustine M, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ 3rd, Singal AG, Yopp AC.

Cancer. 2019 Oct 1;125(19):3428-3436. doi: 10.1002/cncr.32336. Epub 2019 Jul 12.

PMID:
31299089
13.

Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.

Khatri G, Pedrosa I, Ananthakrishnan L, de Leon AD, Fetzer DT, Leyendecker J, Singal AG, Xi Y, Yopp A, Yokoo T.

J Magn Reson Imaging. 2019 Jun 18. doi: 10.1002/jmri.26835. [Epub ahead of print]

PMID:
31209978
14.

Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma.

Fujiwara N, Singal AG, Hoshida Y.

Hepatology. 2019 Jun 17. doi: 10.1002/hep.30813. [Epub ahead of print] No abstract available.

PMID:
31206214
15.

Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.

Tavakkoli A, Singal AG, Waljee AK, Elmunzer BJ, Pruitt SL, McKey T, Rubenstein JH, Scheiman JM, Murphy CC.

Clin Gastroenterol Hepatol. 2019 Jun 13. pii: S1542-3565(19)30641-X. doi: 10.1016/j.cgh.2019.05.059. [Epub ahead of print]

PMID:
31202981
16.

Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease.

Konerman MA, Rogers M, Kenney B, Singal AG, Tapper E, Sharma P, Saini S, Nallamothu B, Waljee A.

BMJ Open Gastroenterol. 2019 Apr 14;6(1):e000271. doi: 10.1136/bmjgast-2018-000271. eCollection 2019.

17.

Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States.

Tavakkoli A, Singal AG, Waljee AK, Scheiman JM, Murphy CC, Pruitt SL, Xuan L, Kwon RS, Law RJ, Elta GH, Wright-Slaughter P, Valley TS, Kubiliun N, Nathan H, Rubenstein JH, Elmunzer BJ.

Cancer Med. 2019 Jul;8(7):3420-3427. doi: 10.1002/cam4.2225. Epub 2019 May 14.

18.

Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.

Rich NE, Yopp AC, Singal AG, Murphy CC.

Clin Gastroenterol Hepatol. 2019 Apr 28. pii: S1542-3565(19)30433-1. doi: 10.1016/j.cgh.2019.04.043. [Epub ahead of print]

PMID:
31042582
19.

Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.

Kanwal F, Singal AG.

Gastroenterology. 2019 Jul;157(1):54-64. doi: 10.1053/j.gastro.2019.02.049. Epub 2019 Apr 12. Review.

PMID:
30986389
20.

Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma.

Hester CA, Rich NE, Singal AG, Yopp AC.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):322-329. doi: 10.6004/jnccn.2018.7105.

PMID:
30959469
21.

Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease.

Zhu M, Lu T, Jia Y, Luo X, Gopal P, Li L, Odewole M, Renteria V, Singal AG, Jang Y, Ge K, Wang SC, Sorouri M, Parekh JR, MacConmara MP, Yopp AC, Wang T, Zhu H.

Cell. 2019 Apr 18;177(3):608-621.e12. doi: 10.1016/j.cell.2019.03.026. Epub 2019 Apr 4.

PMID:
30955891
22.

Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening: A Pre-Post Analysis.

Jain MK, Rich NE, Ahn C, Turner BJ, Sanders JM, Adamson B, Quirk L, Perryman P, Santini NO, Singal AG.

Hepatology. 2019 Jul;70(1):40-50. doi: 10.1002/hep.30638. Epub 2019 May 31.

PMID:
30950085
23.

Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling.

Choi E, Kikuchi S, Gao H, Brodzik K, Nassour I, Yopp A, Singal AG, Zhu H, Yu H.

Nat Commun. 2019 Apr 1;10(1):1473. doi: 10.1038/s41467-019-09318-3.

24.

Surveillance and Diagnosis of Hepatocellular Carcinoma.

Lim J, Singal AG.

Clin Liver Dis (Hoboken). 2019 Jan;13(1):2-5. doi: 10.1002/cld.761. Epub 2019 Feb 21. No abstract available.

25.

AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.

Singal AG, Lim JK, Kanwal F.

Gastroenterology. 2019 Jun;156(8):2149-2157. doi: 10.1053/j.gastro.2019.02.046. Epub 2019 Mar 13. Review.

PMID:
30878469
26.

Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?

Marquardt P, Hoshida Y, Singal AG.

Gastroenterology. 2019 Apr;156(5):1530-1531. doi: 10.1053/j.gastro.2019.03.006. Epub 2019 Mar 5. No abstract available.

PMID:
30849312
27.

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

Hanouneh IA, Alkhouri N, Singal AG.

Clin Mol Hepatol. 2019 Mar 4. doi: 10.3350/cmh.2019.1001. [Epub ahead of print]

28.

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB.

J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019. Review.

29.

For Whom is Hepatocellular Carcinoma Surveillance After Sustained Virologic Response Cost-Effective?

Singal AG, Ioannou GN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1732-1735. doi: 10.1016/j.cgh.2019.02.020. Epub 2019 Feb 14. No abstract available.

PMID:
30772587
30.

Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.

Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB.

Am J Gastroenterol. 2019 Mar;114(3):530-532. doi: 10.14309/ajg.0000000000000068.

PMID:
30699099
31.

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.

Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND.

Gastroenterology. 2019 May;156(6):1683-1692.e1. doi: 10.1053/j.gastro.2019.01.027. Epub 2019 Jan 18.

PMID:
30660729
32.

Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.

Choi DT, Kum HC, Park S, Ohsfeldt RL, Shen Y, Parikh ND, Singal AG.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):976-987.e4. doi: 10.1016/j.cgh.2018.10.031. Epub 2018 Oct 26.

PMID:
30616961
33.

Staging systems of hepatocellular carcinoma: A review.

Tellapuri S, Sutphin PD, Beg MS, Singal AG, Kalva SP.

Indian J Gastroenterol. 2018 Nov;37(6):481-491. doi: 10.1007/s12664-018-0915-0. Epub 2018 Dec 29. Review.

PMID:
30593649
34.

Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program.

Konerman MA, Verma A, Zhao B, Singal AG, Lok AS, Parikh ND.

Liver Transpl. 2019 Mar;25(3):369-379. doi: 10.1002/lt.25398.

PMID:
30582779
35.

Hepatocellular Carcinoma: A Roadmap to Reduce Incidence and Future Burden.

Singal AG, Murphy CC.

J Natl Cancer Inst. 2018 Dec 13. doi: 10.1093/jnci/djy184. [Epub ahead of print] No abstract available.

PMID:
30544135
36.

Hepatocellular Carcinoma Surveillance: An Effective But Complex Process.

Singal AG, Murphy CC.

Gastroenterology. 2019 Mar;156(4):1215. doi: 10.1053/j.gastro.2018.08.066. Epub 2018 Dec 10. No abstract available.

PMID:
30543799
37.

Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups.

Turner BJ, Wang CP, Melhado TV, Bobadilla R, Jain MK, Singal AG.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1356-1363. doi: 10.1016/j.cgh.2018.11.059. Epub 2018 Dec 6.

PMID:
30529733
38.

Screening initiation with FIT or colonoscopy: Post-hoc analysis of a pragmatic, randomized trial.

Murphy CC, Ahn C, Pruitt SL, Hughes AE, Halm EA, Gupta S, Santini NO, McCallister K, Sanders JM, Singal AG, Skinner CS.

Prev Med. 2019 Jan;118:332-335. doi: 10.1016/j.ypmed.2018.11.020. Epub 2018 Dec 1.

PMID:
30508552
39.

Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems.

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):91-98. doi: 10.1158/1055-9965.EPI-18-0452. Epub 2018 Nov 20.

PMID:
30459208
40.

Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.

van der Pol CB, Lim CS, Sirlin CB, McGrath TA, Salameh JP, Bashir MR, Tang A, Singal AG, Costa AF, Fowler K, McInnes MDF.

Gastroenterology. 2019 Mar;156(4):976-986. doi: 10.1053/j.gastro.2018.11.020. Epub 2018 Nov 13.

PMID:
30445016
41.

The Clinical Significance of Crohn Disease Activity at Resection Margins.

Setoodeh S, Liu L, Boukhar SA, Singal AG, Westerhoff M, Waljee AK, Ahmed T, Gopal P.

Arch Pathol Lab Med. 2019 Apr;143(4):505-509. doi: 10.5858/arpa.2018-0011-OA. Epub 2018 Nov 16.

PMID:
30444436
42.

Impact of a Clinical Decision Support System on Guideline Adherence of Surveillance Recommendations for Colonoscopy After Polypectomy.

Magrath M, Yang E, Ahn C, Mayorga CA, Gopal P, Murphy CC, Gupta S, Agrawal D, Halm EA, Borton EK, Skinner CS, Singal AG.

J Natl Compr Canc Netw. 2018 Nov;16(11):1321-1328. doi: 10.6004/jnccn.2018.7050.

PMID:
30442733
43.

The Gut Microbiome and Digestive Health - A New Frontier.

Ananthakrishnan AN, Singal AG, Chang L.

Clin Gastroenterol Hepatol. 2019 Jan;17(2):215-217. doi: 10.1016/j.cgh.2018.10.040. Epub 2018 Oct 29. No abstract available.

PMID:
30385328
44.

Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.

Tang A, Singal AG, Mitchell DG, Hecht EM, Fowler KJ, Kulik L, Parikh ND, Kono Y, Sirlin CB.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1228-1238. doi: 10.1016/j.cgh.2018.10.014. Epub 2018 Oct 13. Review.

PMID:
30326302
45.

Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, Kono Y, Do RK, Mitchell DG, Singal AG, Tang A, Sirlin CB.

Radiology. 2018 Dec;289(3):816-830. doi: 10.1148/radiol.2018181494. Epub 2018 Sep 25. Review.

PMID:
30251931
46.

Reply.

Rich NE, Singal AG.

Gastroenterology. 2018 Oct;155(4):1275-1276. doi: 10.1053/j.gastro.2018.09.026. Epub 2018 Sep 17. No abstract available.

PMID:
30236560
47.

Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase.

Murphy CC, Singal AG, Baron JA, Sandler RS.

Gastroenterology. 2018 Dec;155(6):1716-1719.e4. doi: 10.1053/j.gastro.2018.07.045. Epub 2018 Aug 27.

PMID:
30165046
48.

Colorectal cancer incidence among Hispanics and non-Hispanic Whites in the United States.

Garcia S, Pruitt SL, Singal AG, Murphy CC.

Cancer Causes Control. 2018 Nov;29(11):1039-1046. doi: 10.1007/s10552-018-1077-1. Epub 2018 Aug 28.

PMID:
30155605
49.

Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis.

Bangaru S, Pedersen MR, MacConmara MP, Singal AG, Mufti AR.

Liver Transpl. 2018 Oct;24(10):1357-1362. doi: 10.1002/lt.25285.

PMID:
30141270
50.

Testing for AFP in combination with ultrasound improves early liver cancer detection.

Tzartzeva K, Singal AG.

Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):947-949. doi: 10.1080/17474124.2018.1512855. Epub 2018 Aug 21. No abstract available.

PMID:
30118333

Supplemental Content

Loading ...
Support Center